Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Remodulin in PPHN
NCT02261883Phase 2Terminated
- Sponsor
- United Therapeutics Corporation
- Start
- Jul 2015
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in persistent pulmonary hypertension of the newborn (PPHN) comparing IV Remodulin with Placebo (2 arms). Primary endpoint: Number of Subjects Experiencing Clinical Worsening at Day 14. Started Jul 2015; status: terminated.
02
Drugs
treprostinil
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT02261883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02261883.